Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

ProQR receives FDA approval for Phase I/II QR-421a trial

Usher syndrome is one of the main causes of combined deafness and blindness. Credit: NikiSublime.

  • ProQR Therapeutics

Go Top